Publications and Conferences

Here is a list of our peer-reviewed publications and conference engagements.

Publications

a stack of magazines or books from the max foundation

 

Peer-Reviewed Publications

Cook, G., Wrigglesworth, J. M., & Garcia-Gonzalez, P. (2025) Max Access Solutions: An innovative model to bring life-saving medicines to low- and middle-income countries. Blood Global Hematology, accepted manuscript. On-line ahead of print version. 

Briercheck, E. L., Wrigglesworth, J. M., Garcia-Gonzalez, I., Scheepers, C., Ong, M. C., Venkatesh, V., Stevenson, P., Annamalay, A. A., Coffey, D. G., Anderson, A. B., Garcia-Gonzalez, P., & Wagner, M. J. (2024). Treatment access for gastrointestinal stromal tumor in predominantly low- and middle-income countries. JAMA Network Open, 7(4), e244898. 

Matsuzaki, M., Annamalay, A., Garcia-Gonzalez, P., & Radich, J. (2023). CML outcomes and care delivery during the COVID-19 pandemic in low- and middle-income countries. Current Hematologic Malignancy Reports, 18(1), 1-7.

Rowley, S., Garcia-Gonzalez, P., Radich, J.P., Novakowski, A.K., Usherenko, I., & Babigumira, J.B. (2021). Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries. Cost Effectiveness and Resource Allocation, 19(1), 18.

Umeh, C.A., Garcia-Gonzalez, P., Tremblay, D., & Laing, R. (2020). The survival of patients enrolled in a global direct-to-patient cancer medicine donation program: The Glivec International Patient Assistance Program (GIPAP). EClinicalMedicine, 19, 100257.

Malhotra, H., Radich, J., & Garcia-Gonzalez, P. (2019). Meeting the needs of CML patients in resource-poor countries. Hematology American Society of Hematology Education Program, 2019(1), 433-442.

Garcia-Gonzalez, P., Lopes, G., Schwartz, E., & Shulman, L.N. (2018). The role of humanitarian donations in decreasing preventable mortality from cancer in low-income countries: Models to improve access to life-saving medicines. Journal of Global Oncology, 4, 1-3.

Novakowski, A.K., Garcia-Gonzalez, P., Wrigglesworth, M., & Stergachis, A. (2018). A pharmacovigilance system for treatment access and medical donation programs: The Max Foundation experience. Global Health, 14(1), 76.

Garcia-Gonzalez, P., Boultbee, P., & Epstein, D. (2015). Novel humanitarian aid program: The Glivec International Patient Assistance Program – Lessons learned from providing access to breakthrough targeted oncology treatment in low- and middle-income countries. Journal of Global Oncology, 1(1), 37-45. 

Sadak, K.T., Fultz, K., Mendizabal, A., Reaman, G., Garcia-Gonzalez, P., & Levine, P.H. (2014). International patterns of childhood chronic myeloid leukemia: Comparisons between the United States and resource-restricted nations. Pediatric Blood & Cancer, 61(10), 1774-1778.

Mendizabal, A. M., Garcia-Gonzalez, P., & Levine, P. H. (2013). Regional variations in age at diagnosis and overall survival among patients with chronic myeloid leukemia from low- and middle-income countries. Cancer Epidemiology, 37(3), 247-254.

Garcia-Gonzalez, P., & Schwartz, E.L. (2012). Maximize Life Global Cancer Awareness Campaign: Improving the lives of cancer patients while increasing global awareness of their needs. Studies in Health Technology and Informatics, 172, 27-32.

Conferences 2026

Pat speaking to a group in a meeting references a projector screen

 

2nd Pre-Approval Access to Medicines in Asia-Pacific Conference, March 10-11

Held in Singapore, the 2nd Pre‑Approval Access to Medicines in Asia‑Pacific Conference brings together regulators, industry leaders, and global health experts to advance pathways that provide timely, ethical access to investigational therapies across the region. Max Region Head of Asia & Eastern Europe, Mei Ching Ong, will present.

Operationalize: Expanded Access Programs Summit, March 24-26

The Operationalize: Expanded Access Programs Summit in Boston convenes clinical, regulatory, and operational stakeholders to share best practices for designing and implementing effective, patient‑centered expanded access programs worldwide. On March 25, our VP of Programs Operations, Michael Wrigglesworth, will present on Overcoming Access Barriers in Low & Middle-Income Countries: Operational Lessons from The Max Foundation Model.

ASCO, May 29-June 2

The Max CEO and Programs staff will participate will attend ASCO in Chicago, an annual meeting considered the world’s premier oncology conference, where presenters share groundbreaking research, innovative treatments, and collaborative opportunities to improve cancer care globally.